Evidence map›Paper›PMID 26825607›Full record

ReviewJournal of cancer research and clinical oncology2016

Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets.

C Schindlbeck, U Andergassen, J Jueckstock, B Rack, W Janni, U Jeschke

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cancer research and clinical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Feasibility ofGeburtshilfe und Frauenheilkunde · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. The viable circulating tumor cells with cancer stem cells feature, where is the way out?Journal of experimental & clinical cancer research : CR · 2018
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

C SchindlbeckDepartment of Obstetrics and Gynecology, Klinikum Traunstein, Cuno-Niggl-Str. 3, 83278, Traunstein, Germany.
U AndergassenDepartment of Obstetrics and Gynecology, Campus Innenstadt, Ludwig-Maximilians-University, Maistr. 11, 80337, Munich, Germany.
J JueckstockDepartment of Obstetrics and Gynecology, Campus Innenstadt, Ludwig-Maximilians-University, Maistr. 11, 80337, Munich, Germany.
B RackDepartment of Obstetrics and Gynecology, Campus Innenstadt, Ludwig-Maximilians-University, Maistr. 11, 80337, Munich, Germany.
W JanniDepartment of Obstetrics and Gynecology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.
U JeschkeDepartment of Obstetrics and Gynecology, Campus Innenstadt, Ludwig-Maximilians-University, Maistr. 11, 80337, Munich, Germany. udo.jeschke@med.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DELöwenstein Medical (Germany) · DEUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFrom the early days of pathology back in the nineteenth century until now, there has been an ongoing search for the missing link between solid tumors such as breast cancer and distant metastases, which sometimes occur many years after removal of the primary tumor. The "seed and soil" theory hypothesizes the early dissemination of occult tumor cells into blood or bone marrow, which can persist in a dormant state for a long time and then become precursors of metastases in distant organs which offer appropriate conditions.

methodAdvances in immunocytochemical methods have enabled the enrichment and visualization of those disseminated tumor cells in bone marrow (DTC-BM) or circulating tumor cells (CTC) in blood. Many studies could demonstrate prognostic significance of the detection of DTC-BM or CTC in different stages of breast cancer.

conclusionFurther characterization of those cells by immunocytochemical stainings, fluorescence in situ hybridizations, or PCR-based molecular methods will help to understand the biology of tumor cell dissemination and metastasis formation, as well as to define potential drug targets.

Indexed as

Bone MarrowBreast NeoplasmsCell ProliferationFemaleHumansMolecular Targeted TherapyNeoplastic Cells, CirculatingBone marrowBreast cancerCharacterizationCirculating tumor cellsDetectionDisseminated tumor cellsEnrichmentTargets

Identifiers

PMID26825607
PMCPMC11819178
OpenAlexW2262547870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.